Bio-Techne (TECH) Share-based Compensation Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 2,642.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,642.00% |
| Dec 31, 2025 | -96.72% |
| Sep 30, 2025 | 14.71% |
| Jun 30, 2025 | -35.58% |
| Mar 31, 2025 | -95.06% |
| Dec 31, 2024 | 4,979.33% |
| Sep 30, 2024 | 0.90% |
| Jun 30, 2024 | 438.75% |
| Mar 31, 2024 | 3,950.00% |
| Dec 31, 2023 | -98.15% |
| Sep 30, 2023 | -30.21% |
| Jun 30, 2023 | -124.80% |
| Mar 31, 2023 | -97.79% |
| Dec 31, 2022 | 3,950.00% |
| Sep 30, 2022 | 23.21% |
| Jun 30, 2022 | -33.66% |
| Mar 31, 2022 | 2,164.00% |
| Dec 31, 2021 | -97.44% |
| Sep 30, 2021 | -9.39% |
| Jun 30, 2021 | 110.60% |
| Mar 31, 2021 | -95.05% |
| Dec 31, 2020 | 46.92% |
| Sep 30, 2020 | 47.19% |
| Jun 30, 2020 | -25.98% |
| Mar 31, 2020 | 41.28% |
| Dec 31, 2019 | 53.88% |
| Sep 30, 2019 | -23.91% |
| Jun 30, 2019 | -44.52% |
| Mar 31, 2019 | 21.81% |
| Dec 31, 2018 | 38.00% |
| Sep 30, 2018 | 204.74% |
| Jun 30, 2018 | 329.45% |
| Mar 31, 2018 | 18.27% |
| Dec 31, 2017 | 21.95% |
| Sep 30, 2017 | 18.97% |
| Jun 30, 2017 | 23.89% |
| Mar 31, 2017 | 71.51% |
| Dec 31, 2016 | 76.65% |
| Sep 30, 2016 | 56.53% |
| Jun 30, 2016 | 123.54% |
| Mar 31, 2016 | 79.89% |
| Dec 31, 2015 | 11.86% |
| Sep 30, 2015 | 49.63% |
| Jun 30, 2015 | 38.74% |
| Mar 31, 2015 | 84.00% |
| Dec 31, 2014 | 59.62% |
| Sep 30, 2014 | 139.37% |
| Jun 30, 2014 | 81.22% |
| Mar 31, 2014 | 144.76% |
| Dec 31, 2013 | 65.61% |
| Sep 30, 2013 | 87.79% |
| Jun 30, 2013 | 94.44% |
| Mar 31, 2013 | 18.67% |
| Dec 31, 2012 | -8.51% |
| Sep 30, 2012 | 4.48% |
| Jun 30, 2012 | 25.37% |
| Mar 31, 2012 | 177.01% |
| Dec 31, 2011 | 20.17% |
| Sep 30, 2011 | 113.24% |
| Jun 30, 2011 | 14.86% |
| Mar 31, 2011 | 7.41% |
| Dec 31, 2010 | -8.11% |
| Sep 30, 2010 | 33.33% |